WTO teams up with South Africa’s Department of Trade and Industry, WHO and WIPO to convene workshop on IP and public health

On 7-8 August 2013, the Department of Trade and Industry (the DTI), Republic of South Africa and the World Trade Organization (WTO), in close collaboration with the World Health Organization (WHO) and the World Intellectual Property Organization (WIPO) will hold a National Workshop on Intellectual Property and Public Health in Pretoria. Leading experts from these intergovernmental organizations, Roger Kampf (WTO), Dr. Continue Reading

Uncategorized

2010 FDA (NME) drug approvals: few were based upon US inventions or sold by US companies

In any given year, the U.S. Food and Drug Administration (FDA) grants marketing approval to new drugs. The most important category* are those classified as “new molecular entities” or NMEs. Chen Xingzhi has collected data on the 2010 NMEs included in the FDA Orange Book here: http://goo.gl/W78Tbk. Some of the data are summarized below:

  • Among products listed in the FDA Orange Book in 2010, 15 were classified as NMEs.
  • Among all of the NMEs, 43 patents were listed in the FDA Orange Book, covering 12 of the 15 products.
  • Continue Reading

Uncategorized

IGC25: Draft Recommendation to WIPO General Assembly (24 July 2013)

On 24 July 2013 the Ian Goss (Australia), the facilitator of the 25th session of the WIPO Intergovernmental Committee on Intellectual Property and Genetic Resources, Traditional Knowledge and Folklore (IGC/GRTKF),
prepared the following draft recommendation for consideration by the WIPO General Assembly in September 2013. Currently, WIPO member states are examining the text and will provide their comments on the draft recommendations when the plenary resumes this afternoon.

Continue Reading

Uncategorized

IGC25: General statement of Australia (22 July 2013)

22 July 2013

This was the statement delivered by Australia (Ian Goss, General Manager, IP Australia) on Monday, 22 July 2013.

Australian Statement

Thank you chair

Firstly, I will begin with a negative, last week was perhaps the most frustrating of our meetings this year, in contrast to significant progress on Gr’s [genetic resources] with disclosure proponents agreeing on an administrative approach to disclosure rather than substantive examination, this was a significant shift in position from a number key countries.

Continue Reading

Uncategorized

2013 July 12, Senator Leahy (D-VT) Requests March-In To Ensure Availability of Genetic Testing for BRCA Mutations

On 12 July 2013, Senator Leahy (D-VT), Chair of the Senate Judiciary Committee requested that the NIH exercise its march-in rights under the Bayh-Dole Act to promote genetic testing for BRCA mutations that are associated with a person’s risk for breast and ovarian cancer. In June, the Supreme Court of the United States unanimously ruled that isolated DNA is not patentable, and immediately afterward, other companies stated they would provide BRCA testing. Continue Reading

Uncategorized

WIPO IGC 25 and Traditional Cultural Expressions: Intervention of KEI on Article 3 on the scope of protection

From 15-24 July 2013, the World Intellectual Property Organization (WIPO) is holding the 25th session of the Intergovernmental Committee on Intellectual Property and Genetic Resources, Traditional Knowledge and Folklore (IGC/GRTKF) . Currently, the IGC is chaired by Ambassador Wayne McCook of Jamaica.

Continue Reading

Full time staff position at KEI

Knowledge Ecology International (KEI) is a non-profit organization that focuses on human rights and social dimensions of knowledge governance. Our web page (http://www.keionline.org) provides extensive background on our operations. We maintain offices in Washington, DC and in Geneva Switzerland, and are engaged in a number of initiatives, disputes and negotiations involving intellectual property rights, innovation, and other aspects of the production, management and governance of knowledge resources.

Continue Reading

Uncategorized